Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 11;77(5):768-775.
doi: 10.1093/cid/ciad337.

Neonatal Paenibacilliosis: Paenibacillus Infection as a Novel Cause of Sepsis in Term Neonates With High Risk of Sequelae in Uganda

Affiliations

Neonatal Paenibacilliosis: Paenibacillus Infection as a Novel Cause of Sepsis in Term Neonates With High Risk of Sequelae in Uganda

Jessica E Ericson et al. Clin Infect Dis. .

Abstract

Background: Paenibacillus thiaminolyticus may be an underdiagnosed cause of neonatal sepsis.

Methods: We prospectively enrolled a cohort of 800 full-term neonates presenting with a clinical diagnosis of sepsis at 2 Ugandan hospitals. Quantitative polymerase chain reaction specific to P. thiaminolyticus and to the Paenibacillus genus were performed on the blood and cerebrospinal fluid (CSF) of 631 neonates who had both specimen types available. Neonates with Paenibacillus genus or species detected in either specimen type were considered to potentially have paenibacilliosis, (37/631, 6%). We described antenatal, perinatal, and neonatal characteristics, presenting signs, and 12-month developmental outcomes for neonates with paenibacilliosis versus clinical sepsis due to other causes.

Results: Median age at presentation was 3 days (interquartile range 1, 7). Fever (92%), irritability (84%), and clinical signs of seizures (51%) were common. Eleven (30%) had an adverse outcome: 5 (14%) neonates died during the first year of life; 5 of 32 (16%) survivors developed postinfectious hydrocephalus (PIH) and 1 (3%) additional survivor had neurodevelopmental impairment without hydrocephalus.

Conclusions: Paenibacillus species was identified in 6% of neonates with signs of sepsis who presented to 2 Ugandan referral hospitals; 70% were P. thiaminolyticus. Improved diagnostics for neonatal sepsis are urgently needed. Optimal antibiotic treatment for this infection is unknown but ampicillin and vancomycin will be ineffective in many cases. These results highlight the need to consider local pathogen prevalence and the possibility of unusual pathogens when determining antibiotic choice for neonatal sepsis.

Keywords: ampicillin; empirical antibiotic; hydrocephalus; meningitis; mortality.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. J. N. P. received salary support and stock/stock options from Genentech and N-Power Medicine. He has patents planned, issued, or pending with Genentech and N-Power Medicine. He received honoraria for lectures from the International Human Microbiome Consortia. J. E. E. received consulting fees from AbbVie for participation in a data safety and monitoring board unrelated to the current work. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Figures

Graphical Abstract
Graphical Abstract
This graphical abstract is also available at Tidbit: https://tidbitapp.io/tidbits/neonatal-paenibacilliosis-paenibacillus-infection-as-a-novel-cause-of-sepsis-in-term-neonates-with-high-risk-of-sequelae-in-uganda
Figure 1.
Figure 1.
Presenting signs and outcomes for neonates with Paenibacillus species detected by qPCR during clinical sepsis. Number of neonates presenting to each site with each sign of infection. Numbers at the end of each bar indicate the proportion of neonates at each site who had the corresponding sign of infection. Neonates with the composite poor outcome of death, postinfectious hydrocephalus or moderate/severe neurodevelopmental impairment are indicated in red. Abbreviation: qPCR, quantitative polymerase chain reaction.
Figure 2.
Figure 2.
Outcomes for neonates with clinical sepsis with Paenibacillus negative (PN) and Paenibacillus positive (PP) qPCR results for Paenibacillus thiaminolyticus detection in the CSF at both sites and at Mbarara and Mbale. Abbreviations: CSF, cerebrospinal fluid; qPCR, quantitative polymerase chain reaction.

Comment in

Similar articles

  • Paenibacillus spp infection among infants with postinfectious hydrocephalus in Uganda: an observational case-control study.
    Morton SU, Hehnly C, Burgoine K, Ssentongo P, Ericson JE, Kumar MS, Hagmann C, Fronterre C, Smith J, Movassagh M, Streck N, Bebell LM, Bazira J, Kumbakumba E, Bajunirwe F, Mulondo R, Mbabazi-Kabachelor E, Nsubuga BK, Natukwatsa D, Nalule E, Magombe J, Erickson T, Ngonzi J, Ochora M, Olupot-Olupot P, Onen J, Ssenyonga P, Mugamba J, Warf BC, Kulkarni AV, Lane J, Whalen AJ, Zhang L, Sheldon K, Meier FA, Kiwanuka J, Broach JR, Paulson JN, Schiff SJ. Morton SU, et al. Lancet Microbe. 2023 Aug;4(8):e601-e611. doi: 10.1016/S2666-5247(23)00106-4. Epub 2023 Jun 19. Lancet Microbe. 2023. PMID: 37348522 Free PMC article.
  • Paenibacillus infection with frequent viral coinfection contributes to postinfectious hydrocephalus in Ugandan infants.
    Paulson JN, Williams BL, Hehnly C, Mishra N, Sinnar SA, Zhang L, Ssentongo P, Mbabazi-Kabachelor E, Wijetunge DSS, von Bredow B, Mulondo R, Kiwanuka J, Bajunirwe F, Bazira J, Bebell LM, Burgoine K, Couto-Rodriguez M, Ericson JE, Erickson T, Ferrari M, Gladstone M, Guo C, Haran M, Hornig M, Isaacs AM, Kaaya BN, Kangere SM, Kulkarni AV, Kumbakumba E, Li X, Limbrick DD Jr, Magombe J, Morton SU, Mugamba J, Ng J, Olupot-Olupot P, Onen J, Peterson MR, Roy F, Sheldon K, Townsend R, Weeks AD, Whalen AJ, Quackenbush J, Ssenyonga P, Galperin MY, Almeida M, Atkins H, Warf BC, Lipkin WI, Broach JR, Schiff SJ. Paulson JN, et al. Sci Transl Med. 2020 Sep 30;12(563):eaba0565. doi: 10.1126/scitranslmed.aba0565. Sci Transl Med. 2020. PMID: 32998967 Free PMC article.
  • Type IV Pili Are a Critical Virulence Factor in Clinical Isolates of Paenibacillus thiaminolyticus.
    Hehnly C, Shi A, Ssentongo P, Zhang L, Isaacs A, Morton SU, Streck N, Erdmann-Gilmore P, Tolstoy I, Townsend RR, Limbrick DD, Paulson JN, Ericson JE, Galperin MY, Schiff SJ, Broach JR. Hehnly C, et al. mBio. 2022 Dec 20;13(6):e0268822. doi: 10.1128/mbio.02688-22. Epub 2022 Nov 14. mBio. 2022. PMID: 36374038 Free PMC article.
  • Antibiotics for neonates born through meconium-stained amniotic fluid.
    Kelly LE, Shivananda S, Murthy P, Srinivasjois R, Shah PS. Kelly LE, et al. Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD006183. doi: 10.1002/14651858.CD006183.pub2. Cochrane Database Syst Rev. 2017. PMID: 28658507 Free PMC article. Review.
  • Antibiotic use in neonatal sepsis.
    Yurdakök M. Yurdakök M. Turk J Pediatr. 1998 Jan-Mar;40(1):17-33. Turk J Pediatr. 1998. PMID: 9722468 Review.

Cited by

References

    1. Fleischmann C, Reichert F, Cassini A, et al. . Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis. Arch Dis Child; 2021; 106:745–52. - PMC - PubMed
    1. Al-Matary A, Al Sulaiman M, Al-Otaiby S, Qaraqei M, Al-Matary M. Association between the timing of antibiotics administration and outcome of neonatal sepsis. J Infect Public Health 2022; 15:643–47. - PubMed
    1. Saha SK, Schrag SJ, El Arifeen S, et al. . Causes and incidence of community-acquired serious infections among young children in south Asia (ANISA): an observational cohort study. Lancet 2018; 392:145–59. - PMC - PubMed
    1. Fuchs A, Bielicki J, Mathur S, Sharland M, Van Den Anker JN. Reviewing the WHO guidelines for antibiotic use for sepsis in neonates and children. Paediatr Int Child Health 2018; 38(sup1):S3–S15. - PMC - PubMed
    1. Nebbioso A, Ogundipe OF, Repetto EC, et al. . When first line treatment of neonatal infection is not enough: blood culture and resistance patterns in neonates requiring second line antibiotic therapy in Bangui, Central African Republic. BMC Pediatr 2021; 21:570. - PMC - PubMed

Publication types

Substances